Business of Optometry

Top Story

Bausch + Lomb expands parameters for toric contact lenses

January 22, 2020
Meeting News

Oyster Point’s dry eye nasal spray meets phase 2 endpoints

January 15, 2020
Oyster Point Pharma’s nasal spray treatment for dry eye disease has met its primary endpoints in the phase 2 MYSTIC trial, CEO and President Jeffrey Nau

CustomFlex artificial iris receives transitional pass-through payment status

January 15, 2020
The CustomFlex artificial iris was granted transitional pass-through payment status from CMS, effective Jan. 1, 2020. The artificial iris from VEO Ophthalmics was…

LumiThera completes Series C funding tranche

January 15, 2020
LumiThera has completed the second tranche of its Series C funding round to support clinical testing and commercialization of the Valeda light delivery system in dry…
More Headlines »